Norris Medicines Ltd.

19.21 -0.39 ▼-2.0%

29 February 2024, 04:01:00 PM
Volume: 295

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.norrispharma.com
Market Cap 19.21 Cr.
Enterprise Value(EV) 41.14 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -1.91 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.39 Trailing Twelve Months Ending 2023-12
Book Value / Share -13.73 Trailing Twelve Months Ending 2023-12
Price to Book Value -1.40 Calculated using Price: 19.21
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.00 Cr. 10,000,700 Shares
FaceValue 10
About Norris Medicines Ltd.
The business area of the company is manufacturing of Injections and Medicinal formulations.

Norris Medicines Ltd. Delivery

Delivered Qty
Traded Qty

Norris Medicines Ltd. Performance

1 Day
-1.99%
1 Week
-11.27%
1 Month
-11.76%
3 Month
+42.19%
6 Month
+61.56%
1 Year
+55.55%
2 Year
-45.04%
5 Year
+357.38%
10 Year

Norris Medicines Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -17.93 0.71 -15.52 -76.01 -138.44 0 0 0 0
Return on Capital Employed (%) 3.99 4.06 -4.06 -17.04 -9.18 -18.63 -17.87 -6.59 3.17
Return on Assets (%) -5.8 0.23 -4.18 -13.07 -9.37 -16.48 -29.19 -21.99 -13.88

Norris Medicines Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 5 5 5 2 0 -2 -7 -11 -12 -14
Non Curr. Liab. 6 6 6 5 8 11 13 16 17 19
Curr. Liab. 5 5 10 11 9 8 12 7 8 8
Minority Int.
Equity & Liab. 17 17 20 18 18 17 17 13 13 13
Non Curr. Assets 10 10 11 11 10 9 9 8 8 8
Curr. Assets 7 7 9 8 7 7 8 4 5 5
Misc. Exp. not W/O
Total Assets 17 17 20 18 18 17 17 13 13 13

Norris Medicines Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 19 19 20 14 16 8 12 9 8 5
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 19 19 21 14 16 8 12 9 8 5
Total Expenditure -17 -18 -21 -15 -17 -10 -14 -10 -7 -5
PBIDT 2 1 0 -2 -1 -2 -2 0 1 0
Interest -1 -1 -1 -1 -1 -1 -2 -1 -2 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation -1 0 0 1 0 1 -1 -1 -1 -1
Exceptional Items
PAT -1 0 -1 -3 -2 -3 -5 -3 -2 -2
Adjusted EPS -1 0 -1 -3 -2 -3 -5 -3 -2 -2

Norris Medicines Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 1 1 -1 1 -2 -3 1 -1 1
Cash Fr. Inv. -2 -1 0 -2 0 0 0 0 0
Cash Fr. Finan. 0 0 -1 3 -1 2 3 -1 1 -1
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Norris Medicines Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 34.04 34.04 34.04 34.04 34.04 34.04 34.01 34.01 34.01
Public 65.96 65.96 65.96 65.96 65.96 65.96 65.99 65.99 65.99
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Norris Medicines Ltd. Announcements

Wed, 14 Feb 2024
Outcome Of The Board Meeting Held Today And Financial Results For Dec 31 2023
Outcome of the Board Meeting held today and Financial Results for Dec 31 2023
Thu, 08 Feb 2024
Board Meeting Intimation for December Quarter Results
NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. To consider and take on record the Un-audited Financial Results of the Company for quarter and nine months ended 31st December 2023.2. Any other business with the permission of the Chair.
Tue, 30 Jan 2024
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Proceedings of EOGM and Scrutinizer Report for EOGM held on 30-01-2024

Norris Medicines Ltd. Technical Scans

Wed, 28 Feb 2024
Opening at High Opening at High
Opening at Low Opening at Low
Opening at High for 3 days Opening at High for 3 days
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days

Norris Medicines Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 377,475.37 1,577.95 +0.3%
Cipla Ltd. 119,187.32 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. 107,206.64 6,424.25 -0.1%
Zydus Lifesciences Ltd. 94,418.40 941.90 +1.0%
Divi's Laboratories Ltd. 93,236.55 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. 91,390.97 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. 88,302.11 2,666.80 +2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.38 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 32.14 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.51 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.75 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 67.42 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.78 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.10 2,666.80 +2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.05 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 4.60 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.99 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.86 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.15 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.53 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.35 2,666.80 +2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,666.80 +2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,666.80 +2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,666.80 +2.2%

Norris Medicines Ltd. FAQ's

What is Norris Medicines share price?

Can I buy Norris Medicines shares now?

What is the Market Cap of Norris Medicines?

What is the 52 Week High and Low of Norris Medicines?

What is the trend of Norris Medicines share price?